3295.4000 39.40 (1.21%)
NSE Aug 13, 2025 15:31 PM
Volume: 98,394
 

3295.40
1.21%
Emkay
Following the slump in FY23, DLPL has registered revenue/EBITDA/PAT CAGR of 10%/19%/43%, respectively, over the last two years.
Number of FII/FPI investors decreased from 382 to 358 in Jun 2025 qtr
More from Dr. Lal Pathlabs Ltd.
Recommended